Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$128M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$32.6M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$28.6M |
| 4 |
Tyler Technologies
TYL
|
+$26.9M |
| 5 |
Brown & Brown
BRO
|
+$19.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$284M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Alibaba
BABA
|
+$158M |
| 5 |
Amazon
AMZN
|
+$104M |
Sector Composition
| 1 | Technology | 21.52% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.17% |
| 5 | Industrials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Primoris Services
PRIM
$6.59B
| $1.84M | ﹤0.01% |
82,900
+2,700
| +3% | +$60.1K |
|
|
TBI
1777
Trueblue
TBI
$179M
| $1.84M | ﹤0.01% |
76,600
+2,100
| +3% | +$50.5K |
|
1778
ProPetro Holding
PUMP
$484M
| $1.84M | ﹤0.01% |
163,400
+3,300
| +2% | +$37.1K |
|
|
ENDP
1779
DELISTED
Endo International plc
ENDP
| $1.83M | ﹤0.01% |
390,100
+8,100
| +2% | +$38K |
|
1780
Heartland Express
HTLD
$656M
| $1.82M | ﹤0.01% |
86,300
+1,600
| +2% | +$33.7K |
|
|
SVM
1781
Silvercorp Metals
SVM
$1.15B
| $1.82M | ﹤0.01% |
322,300
+4,400
| +1% | +$24.8K |
|
1782
Karyopharm Therapeutics
KPTI
$55.9M
| $1.82M | ﹤0.01% |
6,317
+280
| +5% | +$80.5K |
|
|
ANAT
1783
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.81M | ﹤0.01% |
15,413
+200
| +1% | +$23.5K |
|
1784
TG Therapeutics
TGTX
$5.1B
| $1.81M | ﹤0.01% |
163,300
+9,900
| +6% | +$110K |
|
1785
Triumph Financial, Inc.
TFIN
$1.4B
| $1.81M | ﹤0.01% |
47,600
+400
| +0.8% | +$15.2K |
|
1786
Chord Energy
CHRD
$5.96B
| $1.8M | ﹤0.01% |
554,450
+10,700
| +2% | +$34.8K |
|
1787
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $1.8M | ﹤0.01% |
100,100
+2,400
| +2% | +$43.2K |
|
1788
PJT Partners
PJT
$4.47B
| $1.8M | ﹤0.01% |
39,935
| – | – |
|
|
CHK
1789
DELISTED
Chesapeake Energy Corporation
CHK
| $1.8M | ﹤0.01% |
10,913
+181
| +2% | +$29.9K |
|
1790
Cohu
COHU
$964M
| $1.8M | ﹤0.01% |
78,650
+2,900
| +4% | +$66.3K |
|
1791
United Fire Group
UFCS
$807M
| $1.8M | ﹤0.01% |
41,100
+900
| +2% | +$39.4K |
|
|
LMNX
1792
DELISTED
Luminex Corp
LMNX
| $1.8M | ﹤0.01% |
77,500
+1,600
| +2% | +$37.1K |
|
1793
Oil States International
OIS
$341M
| $1.79M | ﹤0.01% |
110,000
+3,100
| +3% | +$50.6K |
|
|
NSTG
1794
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.79M | ﹤0.01% |
64,400
+2,100
| +3% | +$58.4K |
|
1795
Encore Capital Group
ECPG
$1.02B
| $1.79M | ﹤0.01% |
50,500
+1,300
| +3% | +$46K |
|
|
MAXR
1796
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $1.79M | ﹤0.01% |
+114,000
| New | +$1.79M |
|
1797
Scansource
SCSC
$974M
| $1.79M | ﹤0.01% |
48,300
+500
| +1% | +$18.5K |
|
1798
CTS Corp
CTS
$1.23B
| $1.78M | ﹤0.01% |
59,400
+900
| +2% | +$27K |
|
1799
1st Source
SRCE
$1.55B
| $1.78M | ﹤0.01% |
34,289
+600
| +2% | +$31.1K |
|
1800
Ultra Clean Holdings
UCTT
$1.14B
| $1.78M | ﹤0.01% |
75,700
+3,100
| +4% | +$72.8K |
|